Indiana Alzheimer's Disease Research Center
A
Andrew Saykin, PsyD
Primary Investigator
Recruiting
65 years - 100 years
All
Phase
N/A
2500 participants needed
1 Location
Brief description of study
What is the purpose of this study?
The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer's disease, those who have other disorders of memory and thinking, and older individuals who have normal memory and thinking.
Detailed description of study
What will happen during the study?
- All subjects who enroll in the study will have an initial visit (3-5 hrs) and then have yearly visits.
- All in person visits include neuropsychological testing, physical and neurological examination, and completion of a questionnaire by a person who knows the subject well.
- Telephone follow-up visits will be done at the discretion of the PI and participant based on availability and health.
- Audio recordings of verbal memory and verbal fluency subtests will be obtained with subsequent transcription to improve scoring accuracy.
- A sample of blood (85 ml, about 6 tablespoons) will be drawn at each in-person visit for biomarker and genetic research. The IADRC prefers that blood be drawn following a fasting of 6 – 8 hours.
Participants will be compensated for their participation.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Alzheimer's Disease,Dementia
-
Age: 65 years - 100 years
-
Gender: All
Inclusion Criteria
- Have normal cognition or mild to moderate memory problems
- Have a study partner: a relative or friend of 10+ years who can answer questions about your memory during study visits
Exclusion Criteria
- Pregnant or nursing
- Major medical or psychiatric conditions
- Claustrophobic
Updated on
01 Aug 2024.
Study ID: 1011003338, RADY-NIA-SAYKIN-IADC
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
